Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Synthesis and functional studies of self-adjuvanting multicomponent anti-HER2 cancer vaccines
Qi Feng*abcd,
Xiaoyue Yube,
Yixue Wangabcd,
Shiyang Liabcd and
Yang Yang*f
aDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China. E-mail: fengqi2019@zzu.edu.cn
bResearch Institute of Nephrology, Zhengzhou University, Zhengzhou 450052, P. R. China
cHenan Province Research Center for Kidney Disease, Zhengzhou 450052, P. R. China
dKey Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou 450052, P. R. China
eDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China
fClinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China. E-mail: yangyangbio@163.com
First published on 16th November 2021
Abstract
Correction for ‘Synthesis and functional studies of self-adjuvanting multicomponent anti-HER2 cancer vaccines’ by Qi Feng et al., RSC Adv., 2021, 11, 33814–33822, DOI: 10.1039/D1RA06146A.
The authors regret that the authors were affiliated with the incorrect institutions in the original manuscript. The corrected author list and affiliations are as shown above.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2021 |